e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Prognosis and diagnosis of thoracic malignancies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Negative predictive value of autofluorescence imaging (AFI) in patients at high risk for lung cancer
O. Bauwens, P. Pierard, J. Faber, T. Prigogine, J. P. Sculier, V. Ninane (Brussels, Belgium)
Source:
Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Session:
Prognosis and diagnosis of thoracic malignancies
Session type:
Thematic Poster Session
Number:
3890
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Bauwens, P. Pierard, J. Faber, T. Prigogine, J. P. Sculier, V. Ninane (Brussels, Belgium). Negative predictive value of autofluorescence imaging (AFI) in patients at high risk for lung cancer. Eur Respir J 2007; 30: Suppl. 51, 3890
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Negative predictive value of EBUS in lung cancer staging
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012
Lung cancer screening with low dose spiral CT and autofluorescence bronchoscopy in high risk group
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Negative predictive value of pleural fluid cytology in patients with a background of cancer.
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019
The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients.
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
100 month survival of patients treated surgically for lung cancer: predictive value of magnetic resonance (MR) staging
Source: Eur Respir J 2002; 20: Suppl. 38, 601s
Year: 2002
The best predictor of COVID-19 pneumonia progression during lung ultrasound (LUS)
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
The clinical value of fluorescence bronchoscopy in predicting survivals in patients with small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 150s
Year: 2006
Combination of the narrow band imaging (NBI) and autofluorescence videobronchoscopy (AFI) improves assessment of central lung cancer extension
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010
The value of autofluorescence bronchoscopy in the pre-operative staging of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 525s
Year: 2004
Correlation between standardised uptake value on PET scans, tumour characteristics and survival in resected lung cancer patients
Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Year: 2007
Scintigraphy with
99m
Tc-depreotide has a high sensitivity in detecting lung cancer
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007
The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer
Source: Eur Respir J 2006; 28: 915-919
Year: 2006
The diagnostic value of serum tumor markers in newly diagnosed lung cancer patients
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Narrow band imaging (NBI) for early lung cancer detection
Source: Annual Congress 2006 - Hot technologies in bronchoscopy and thoracoscopy
Year: 2006
Low dose CT scanning for early lung cancer detection in an Irish population - results of baseline
Source: Eur Respir J 2002; 20: Suppl. 38, 184s
Year: 2002
Low-radiation-dose computed tomography on lung cancer screening. Prevalence cut-off
Source: Eur Respir J 2005; 26: Suppl. 49, 536s
Year: 2005
Identification of genes with diagnostic and prognostic value in lung cancer.
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Negative predictive value of EBUS-TBNA in mediastinal staging of lung cancer
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020
A value of ultrasonographic predictors of malignancy in left adrenal gland in lung cancer patients – a comparison of EUS-b, CT and PET-CT
Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies
Year: 2021
Identification of p-stage I NSCLC patients with high risk of recurrence and poor prognosis by tumor marker index (TMI)
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept